Clinical TrialID 7860

Mangos to Reduce Cardiometabolic Risk Markers

NCT06029647

Healthy

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7860
Evidence Id
7860
Core Evidence Id
7860
Source Clinical Trial Id
7857
Herb2 Clinical Trial Id
HBCT007857
Nct Id
NCT06029647
Title
Mangos to Reduce Cardiometabolic Risk Markers
Status
Active_Not_Recruiting
Phase
Study Result
No
Study Condition
Healthy
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Intervention
OTHER: Mango|OTHER: vanilla wafers
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Intervention Purpose
Basic_Science
Gender
All
Age
Adult
Enrollment
40
Outcome Measure
Blood pressure (mm Hg), Systolic and diastolic blood pressure will be measured., 16 weeks for mango consumption and 16 weeks for vanilla wafer consumption
Sponsor Collaborator
California State Polytechnic University, Pomona
Funded By
OTHER
Location
California State Polytechnic University, Pomona, Pomona, California, 91768, United States
Other Id
603036
Start Date
2023-09-18
Primary Completion Date
2024-10-01
Completion Date
2024-10-01
First Posted
2023-09-08
Results First Posted
Last Update Posted
2024-02-09
Study Document
Study Url
https://clinicaltrials.gov/study/NCT06029647
Title Cn
Title En
Mangos to Reduce Cardiometabolic Risk Markers
Bilingual Status
semi_complete